Plant Extracts That Protect the Body's Natural Pain-Relieving Peptides

California poppy and Corydalis extracts prevented enzymatic breakdown of enkephalin pain-relieving peptides, suggesting a mechanism for traditional pain uses.

Reimeier, C et al.·Arzneimittel-Forschung·1995·Preliminary Evidencein-vitro
RPEP-00340In VitroPreliminary Evidence1995RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Eschscholtzia californica and Corydalis cava extracts inhibited peroxidase- and tyrosinase-mediated dimerization and oxidation of enkephalin peptides.

Key Numbers

How They Did This

In vitro assays measuring enzymatic dimerization and oxidation of met-enkephalin and leu-enkephalin in the presence or absence of plant extracts. Alkaloid content of extracts characterized.

Why This Research Matters

These plants have long traditions in herbal medicine for pain and anxiety. This study provides a potential biochemical mechanism: protecting natural opioid peptides from breakdown.

The Bigger Picture

Rather than adding external opioids, these plants may work by protecting the body's own opioid peptides from breakdown — a fundamentally different approach to pain management that could have fewer side effects than opioid drugs.

What This Study Doesn't Tell Us

In vitro study only. The plant extract concentrations tested may not be achievable in the body through oral consumption. Many other compounds in these extracts have their own effects.

Questions This Raises

  • ?Can these plant extracts achieve protective concentrations in the brain after oral consumption?
  • ?Which specific alkaloids in these extracts are responsible for the enkephalin-protecting effects?

Trust & Context

Key Stat:
2 plant species California poppy and Corydalis both protected enkephalins from enzymatic breakdown
Evidence Grade:
Preliminary — in vitro enzyme inhibition study. Does not demonstrate that this mechanism operates in living organisms after oral consumption.
Study Age:
Published in 1995. Interest in natural enkephalinase inhibitors has continued, though clinical evidence for these specific plants remains limited.
Original Title:
Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins.
Published In:
Arzneimittel-Forschung, 45(2), 132-6 (1995)
Database ID:
RPEP-00340

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How might these plants reduce pain naturally?

Instead of adding opioids, these plant extracts may protect your body's own pain-relieving enkephalin peptides from being broken down by enzymes, allowing them to work longer.

Can I use these plants for pain relief?

While the biochemical mechanism is plausible, this was an in vitro study. Whether drinking California poppy tea achieves sufficient concentrations in the brain to protect enkephalins is unproven.

Read More on RethinkPeptides

Cite This Study

RPEP-00340·https://rethinkpeptides.com/research/RPEP-00340

APA

Reimeier, C; Schneider, I; Schneider, W; Schäfer, H L; Elstner, E F. (1995). Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins.. Arzneimittel-Forschung, 45(2), 132-6.

MLA

Reimeier, C, et al. "Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins.." Arzneimittel-Forschung, 1995.

RethinkPeptides

RethinkPeptides Research Database. "Effects of ethanolic extracts from Eschscholtzia californica..." RPEP-00340. Retrieved from https://rethinkpeptides.com/research/reimeier-1995-effects-of-ethanolic-extracts

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.